Table 1.

CD2 Differentially Affects the Proportions of Thymocyte Subsets in TCR Transgenic Mice

MutationNo. Thymocytes × 10−7 (Mean ± SEM)Percent of Total Thymocytes (mean ± SEM)
CD48CD4+8+CD4+8CD48+
H-Y 9.8 ± 0.3 15 ± 1.7 61 ± 3.0 8.5 ± 1.0 16 ± 1.2 
H-Y/CD2o 9.5 ± 1.5 15 ± 1.6 46 ± 3.7 8.2 ± 0.2 31 ± 3.2 
2C 1.8 ± 0.5 51 ± 0.6 19 ± 2.0 9.4 ± 1.7 21 ± 1.8 
2C/CD2o 1.9 ± 0.4 56 ± 2.6 13 ± 2.3 9.7 ± 1.2 21 ± 1.3 
MutationNo. Thymocytes × 10−7 (Mean ± SEM)Percent of Total Thymocytes (mean ± SEM)
CD48CD4+8+CD4+8CD48+
H-Y 9.8 ± 0.3 15 ± 1.7 61 ± 3.0 8.5 ± 1.0 16 ± 1.2 
H-Y/CD2o 9.5 ± 1.5 15 ± 1.6 46 ± 3.7 8.2 ± 0.2 31 ± 3.2 
2C 1.8 ± 0.5 51 ± 0.6 19 ± 2.0 9.4 ± 1.7 21 ± 1.8 
2C/CD2o 1.9 ± 0.4 56 ± 2.6 13 ± 2.3 9.7 ± 1.2 21 ± 1.3 

Five mice (6 to 12 weeks old) were analyzed per group. Thymocytes from the indicated TCR transgenic mice were stained with phycoerythrin-labeled anti-CD4 and fluorescein isothiocyanate-labeled anti-CD8 MoAbs and analyzed in the FACScan flow cytometer. The total number of viable thymocytes recovered from these transgenic lines are indicated.

or Create an Account

Close Modal
Close Modal